ESMO Honours Outstanding Oncology Professionals
ESMO Award, ESMO Lifetime Achievement Awarda and Hamilton Fairley Award
ESMO Media Releases
Is Europe Putting Cancer Research at Risk?
ESMO concerned that the proposed EU General Data Protection Regulation could make cancer research impossible and add a significant burden to cancer patients
Phase III Trial Shows Improved Survival with TAS-102 in Metastatic Colorectal Cancer Refractory to Standard Therapies
The new combination agent TAS-102 is able to improve overall survival compared to placebo in patients whose metastatic colorectal cancer is refractory to standard therapies, researchers said at the ESMO 16th World Congress on Gastrointestinal Cancer in Barcelona
Phase III Trial Shows Equivalent Survival for Cetuximab or Bevacizumab with Combination Chemotherapy in Metastatic Colorectal Cancer
For patients with KRAS wild-type untreated colorectal cancer, adding cetuximab or bevacizumab to combination chemotherapy offers equivalent survival, researchers said at the ESMO 16th World Congress on Gastrointestinal Cancer in Barcelona
International Phase 3 Trial Shows Survival Benefit of MM-398 Added to Standard Treatment in Metastatic Pancreatic Cancer
Adding the novel MM-398 to standard treatment for metastatic pancreatic cancer patients who have already received gemcitabine improves survival, researchers said at the ESMO 16th World Congress on Gastrointestinal Cancer in Barcelona.
SSIF Award for Excellence in Medical Oncology Education Goes to ESMO President-Elect
Fortunato Ciardiello to receive award during the ESMO 16th World Congress on Gastrointestinal Cancer
Medical Research Safeguarded in Europe
ESMO welcomes the adoption of the Clinical Trials Regulation by the European Union
ESMO Survey Sheds Light on Common Clinical Practice for Incompletely Resected Lung Cancer
A survey by the ESMO Young Oncologists Committee
ESMO, UICC, NCD Alliance and other endorsing partners issue joint statement on palliative care at 67th World Health Assembly
67th World Health Assembly adopts the ‘Strengthening of palliative care as a component of integrated treatment throughout the life course’ resolution
Call for More Awareness of Sexual Dysfunction in Lung Cancer Patients
Doctors urged to pay more attention to an issue that has major consequences for quality of life, experts call at the 4th European Lung Cancer Conference
ELCC 2014 Press Release: Immunotherapy Data Heralds New Era of Lung Cancer Treatment
In the treatment of lung cancer, immunotherapy “has come of age and is here to stay” expert says at the 4th European Lung Cancer Conference
ESMO Interview: Franco Cavalli Comments on the Release of the World Cancer Report 2014
Global Approach Needed for Cancer Control